Task: Answer the MCQ question.
Question: Which compound exhibits a -1.223% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: Fc1ccccc1Cc1noc(CN2CCCC(CN3CCOCC3)C2)n1
b: Cc1ccc(NC(=O)C2CCCO2)cc1[N+](=O)[O-]
Answer: a. Fc1ccccc1Cc1noc(CN2CCCC(CN3CCOCC3)C2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Fc1ccccc1Cc1noc(CN2CCCC(CN3CCOCC3)C2)n1
Fc1ccccc1Cc1noc(CN2CCCC(CN3CCOCC3)C2)n1
4-[[1-[[3-[(2-fluorophenyl)methyl]-1,2,4-oxadiazol-5-yl]methyl]piperidin-3-yl]methyl]morpholine